HomeCompareWENAW vs PM

WENAW vs PM: Dividend Comparison 2026

WENAW yields 5063.29% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WENAW wins by $70304199583247.83M in total portfolio value
10 years
WENAW
WENAW
● Live price
5063.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70304199583247.88M
Annual income
$67,674,944,133,659,165,000.00
Full WENAW calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — WENAW vs PM

📍 WENAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWENAWPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WENAW + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WENAW pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WENAW
Annual income on $10K today (after 15% tax)
$430,379.75/yr
After 10yr DRIP, annual income (after tax)
$57,523,702,513,610,285,000.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, WENAW beats the other by $57,523,702,513,610,285,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WENAW + PM for your $10,000?

WENAW: 50%PM: 50%
100% PM50/50100% WENAW
Portfolio after 10yr
$35152099791623.96M
Annual income
$33,837,472,066,829,582,000.00/yr
Blended yield
96.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

WENAW
No analyst data
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WENAW buys
0
PM buys
0
No recent congressional trades found for WENAW or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWENAWPM
Forward yield5063.29%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$70304199583247.88M$49.6K
Annual income after 10y$67,674,944,133,659,165,000.00$2,492.02
Total dividends collected$70126381934526.08M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: WENAW vs PM ($10,000, DRIP)

YearWENAW PortfolioWENAW Income/yrPM PortfolioPM Income/yrGap
1← crossover$517,029$506,329.11$11,648$408.29+$505.4KWENAW
2$25,019,286$24,466,064.78$13,589$495.90+$25.01MWENAW
3$1,133,242,195$1,106,471,558.74$15,877$603.21+$1133.23MWENAW
4$48,051,212,061$46,838,642,912.48$18,580$734.88+$48051.19MWENAW
5$1,907,518,068,513$1,856,103,271,607.74$21,781$896.75+$1907518.05MWENAW
6$70,903,526,356,852$68,862,482,023,543.80$25,578$1,096.12+$70903526.33MWENAW
7$2,468,069,984,799,694$2,392,203,211,597,861.50$30,092$1,342.17+$2468069984.77MWENAW
8$80,463,110,629,918,740$77,822,275,746,183,060.00$35,470$1,646.46+$80463110629.88MWENAW
9$2,457,248,083,727,765,000$2,371,152,555,353,752,000.00$41,892$2,023.58+$2457248083727.72MWENAW
10$70,304,199,583,247,880,000$67,674,944,133,659,165,000.00$49,578$2,492.02+$70304199583247.83MWENAW

WENAW vs PM: Complete Analysis 2026

WENAWStock

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Full WENAW Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this WENAW vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WENAW vs SCHDWENAW vs JEPIWENAW vs OWENAW vs KOWENAW vs MAINWENAW vs MOWENAW vs BTIWENAW vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.